SOFWAVE MEDICAL
Sector: Healthcare & Life Sciences
About SOFWAVE MEDICAL
Sofwave Medical (TASE: SOFW) is an emerging leader in energy-based aesthetic devices. In early 2026, the company is scaling its global footprint following record 2025 revenues of $87.5M and recent regulatory clearances in Japan and Brazil, while exploring a potential U.S. public offering.
Products
SUPERB™
Ultrasound technology delivers energy at a depth of 1.5mm in a controlled, parallel, and uniform manner to induce coagulation and subsequent revitalization of the three key elements for regenerated rejuvenated skin: collagen, elastin, and hyaluronic acid.